-
公开(公告)号:US07388025B2
公开(公告)日:2008-06-17
申请号:US11590571
申请日:2006-10-31
申请人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
发明人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
IPC分类号: A61K31/42 , C07D413/02
CPC分类号: C07D413/06 , C07D413/14
摘要: The present invention is concerned with 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives of formula I wherein R1, R2, and R3 are as defined in the specification and claims and with their pharmaceutically acceptable acid addition salts. These compounds have a high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
摘要翻译: 本发明涉及式I的3-芳基 - 异恶唑-4-羰基 - 苯并呋喃衍生物,其中R 1,R 2,R 3和R 3, SUP>如说明书和权利要求书及其药学上可接受的酸加成盐所定义。 这些化合物对GABA Aα5受体结合位点具有高亲和力和选择性,并且可用作认知增强剂或用于治疗诸如阿尔茨海默病的认知障碍。
-
公开(公告)号:US20070105922A1
公开(公告)日:2007-05-10
申请号:US11590571
申请日:2006-10-31
申请人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
发明人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
IPC分类号: A61K31/42 , C07D413/02
CPC分类号: C07D413/06 , C07D413/14
摘要: The present invention is concerned with 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives of formula I wherein R1, R2, and R3 are as defined in the specification and claims and with their pharmaceutically acceptable acid addition salts. These compounds have a high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
摘要翻译: 本发明涉及式I的3-芳基 - 异恶唑-4-羰基 - 苯并呋喃衍生物,其中R 1,R 2,R 3和R 3, SUP>如说明书和权利要求书及其药学上可接受的酸加成盐所定义。 这些化合物对GABA Aα5受体结合位点具有高亲和力和选择性,并且可用作认知增强剂或用于治疗诸如阿尔茨海默病的认知障碍。
-
3.
公开(公告)号:US20070082936A1
公开(公告)日:2007-04-12
申请号:US11543178
申请日:2006-10-04
申请人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
发明人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
IPC分类号: A61K31/42 , C07D413/02
CPC分类号: C07D413/14
摘要: The present invention is concerned with aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives of formula I wherein R1, R2, R3, R4, and R5 are as defined in the specification and claims and with their pharmaceutically acceptable acid addition salts. The invention also relates to methods for preparing such compounds. This class of compounds has a high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease. Thus, the invention also is concerned with pharmaceutical compositions containing compounds of formula I or their pharmaceutically acceptable acid addition salts and methods for the treatment of GABA A α5 mediated diseases, including Alzheimer's disease.
摘要翻译: 本发明涉及式I的芳基 - 异恶唑-4-羰基 - 吲哚 - 羧酸酰胺衍生物,其中R 1,R 2,R 3, R 4,R 4和R 5如说明书和权利要求书及其药学上可接受的酸加成盐所定义。 本发明还涉及制备这些化合物的方法。 这类化合物对GABA Aα5受体结合位点具有高亲和力和选择性,可能作为认知增强剂或治疗阿尔茨海默病等认知障碍。 因此,本发明还涉及含有式I化合物或其药学上可接受的酸加成盐的药物组合物和用于治疗包括阿尔茨海默氏病在内的GABA Aα5介导的疾病的方法。
-
公开(公告)号:US20070066668A1
公开(公告)日:2007-03-22
申请号:US11520394
申请日:2006-09-13
申请人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
发明人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
IPC分类号: A61K31/42 , C07D413/02
CPC分类号: C07D413/14 , C07D413/06 , C07D451/06
摘要: The present invention is concerned with aryl-isoxazole-4-carbonyl-pyrrole-2-carboxylic acid amide derivatives of formula wherein R1, R2, R3, R4, and R5, and m are as defined herein and with their pharmaceutically acceptable acid addition salts. This class of compounds have high affinity and selectivity for GABA A α5 receptor binding sites and therefore may be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
摘要翻译: 本发明涉及下式的芳基 - 异恶唑-4-羰基 - 吡咯-2-羧酸酰胺衍生物其中R 1,R 2,R 3, R 4,R 4和R 5,m如本文所定义,并与其药学上可接受的酸加成盐反应。 这类化合物对GABA Aα5受体结合位点具有高亲和力和选择性,因此可用作认知增强剂或治疗认知障碍如阿尔茨海默病。
-
5.
公开(公告)号:US07378435B2
公开(公告)日:2008-05-27
申请号:US11543178
申请日:2006-10-04
申请人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
发明人: Bernd Buettelmann , Bo Han , Henner Knust , Matthias Nettekoven , Andrew Thomas
IPC分类号: A61K31/42 , C07D413/02
CPC分类号: C07D413/14
摘要: The present invention is concerned with aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives of formula I wherein R1, R2, R3, R4, and R5 are as defined in the specification and claims and with their pharmaceutically acceptable acid addition salts. The invention also relates to methods for preparing such compounds. This class of compounds has a high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease. Thus, the invention also is concerned with pharmaceutical compositions containing compounds of formula I or their pharmaceutically acceptable acid addition salts and methods for the treatment of GABA Aα5 mediated diseases, including Alzheimer's disease.
摘要翻译: 本发明涉及式I的芳基 - 异恶唑-4-羰基 - 吲哚 - 羧酸酰胺衍生物,其中R 1,R 2,R 3, R 4,R 4和R 5如说明书和权利要求书及其药学上可接受的酸加成盐所定义。 本发明还涉及制备这些化合物的方法。 这类化合物对GABA Aα5受体结合位点具有高亲和力和选择性,可能作为认知增强剂或治疗阿尔茨海默病等认知障碍。 因此,本发明还涉及含有式I化合物或其药学上可接受的酸加成盐和用于治疗包括阿尔茨海默病在内的GABA Aalpha5介导的疾病的方法的药物组合物。
-
公开(公告)号:US07528136B2
公开(公告)日:2009-05-05
申请号:US12129718
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , A61K31/4725 , A61K31/401 , C07D401/06 , C07D207/16 , C07D487/10
CPC分类号: C07D207/16 , C07D401/06 , C07D471/10
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, R4, R5, X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof which are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R 1,R 2,R 3,R 4,R 5,X,n和o如本文所定义的式I化合物及其药学上可接受的酸加成盐,其为高度潜在的NK-3受体拮抗剂 抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)的治疗。
-
公开(公告)号:US20080306086A1
公开(公告)日:2008-12-11
申请号:US12129718
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/02 , C07D217/00 , A61K31/4709 , C07D211/00 , A61K31/454 , A61K31/438 , A61P25/00
CPC分类号: C07D207/16 , C07D401/06 , C07D471/10
摘要: The present invention relates to a compound of formula I wherein R2 R3, R4, R5, X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof which are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R2 R3,R4,R5,X,n和o如本文所定义的式I化合物及其药学上可接受的酸加成盐,其为高度潜在的NK-3受体拮抗剂,用于治疗 抑郁症,疼痛,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)。
-
8.
公开(公告)号:US07501422B2
公开(公告)日:2009-03-10
申请号:US12129720
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/04
CPC分类号: C07D403/12
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, and n are as defined herein or to a pharmaceutically acceptable acid addition salt thereof. These compounds are NK3 receptor antagonists, useful for the treatment of such disorders as depression, pain, bipolar disorders, psychosis, Parkinson's disease, schizophrenia, anxiety, and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R 1,R 2,R 3和n如本文所定义或其药学上可接受的酸加成盐的式I化合物。 这些化合物是NK3受体拮抗剂,可用于治疗抑郁症,疼痛,双相性精神障碍,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)等疾病。
-
9.
公开(公告)号:US20080306089A1
公开(公告)日:2008-12-11
申请号:US12129720
申请日:2008-05-30
申请人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
发明人: Bo Han , Henner Knust , Matthias Nettekoven , Hasane Ratni , Xihan Wu
IPC分类号: A61K31/496 , C07D403/14 , A61P25/00
CPC分类号: C07D403/12
摘要: The present invention relates to a compound of formula I wherein R1, R2, R3, and n are as defined herein or to a pharmaceutically acceptable acid addition salt thereof. These compounds are NK3 receptor antagonists, useful for the treatment of such disorders as depression, pain, bipolar disorders, psychosis, Parkinson's disease, schizophrenia, anxiety, and attention deficit hyperactivity disorder (ADHD).
摘要翻译: 本发明涉及其中R 1,R 2,R 3和n如本文所定义或其药学上可接受的酸加成盐的式I化合物。 这些化合物是NK3受体拮抗剂,可用于治疗抑郁症,疼痛,双相性精神障碍,精神病,帕金森病,精神分裂症,焦虑和注意缺陷多动障碍(ADHD)等疾病。
-
公开(公告)号:US08404679B2
公开(公告)日:2013-03-26
申请号:US13452981
申请日:2012-04-23
申请人: Caterina Bissantz , Philippe Jablonski , Henner Knust , Andreas Koblet , Anja Limberg , Matthias Nettekoven , Hasane Ratni , Claus Riemer
发明人: Caterina Bissantz , Philippe Jablonski , Henner Knust , Andreas Koblet , Anja Limberg , Matthias Nettekoven , Hasane Ratni , Claus Riemer
IPC分类号: A61K31/496 , A61K31/498 , A61K31/5377 , A61K31/541 , C07D207/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D417/06 , A61K31/454 , A61K31/501 , C07D401/06 , C07D401/14 , C07D403/06 , C07D405/06
CPC分类号: C07D207/14 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D413/10
摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, Ar and n are as defined herein and pharmaceutically active salts, racemic mixtures, enantiomers, optical isomers or tautomeric forms thereof. The compounds can be used for the treatment of depression, anxiety or schizophrenia.
摘要翻译: 本发明涉及其中R 1,R 2,R 3,Ar和n如本文所定义的药物活性盐,外消旋混合物,对映异构体,旋光异构体或其互变异构形式的式I化合物。 这些化合物可用于治疗抑郁,焦虑或精神分裂症。
-
-
-
-
-
-
-
-
-